Drugs / WOL071-007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02576093 | Mar 2014 → Jul 2015 | atopic eczema | Dr. August Wolff GmbH & Co. KG Arzneimittel | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WOL071-007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02576093 ↗ |
| Action | Activate | “novel k-opioid receptor agonist” NCT02576093 ↗ |
| Route | Topical | “for topical application” NCT02576093 ↗ |